Gestational weight change in a diverse pregnancy cohort and mortality over 50 years: a prospective observational cohort study.

IF 98.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL
The Lancet Pub Date : 2023-11-18 Epub Date: 2023-10-19 DOI:10.1016/S0140-6736(23)01517-9
Stefanie N Hinkle, Sunni L Mumford, Katherine L Grantz, Pauline Mendola, James L Mills, Edwina H Yeung, Anna Z Pollack, Sonia M Grandi, Rajeshwari Sundaram, Yan Qiao, Enrique F Schisterman, Cuilin Zhang
{"title":"Gestational weight change in a diverse pregnancy cohort and mortality over 50 years: a prospective observational cohort study.","authors":"Stefanie N Hinkle, Sunni L Mumford, Katherine L Grantz, Pauline Mendola, James L Mills, Edwina H Yeung, Anna Z Pollack, Sonia M Grandi, Rajeshwari Sundaram, Yan Qiao, Enrique F Schisterman, Cuilin Zhang","doi":"10.1016/S0140-6736(23)01517-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>High weight gain in pregnancy is associated with greater postpartum weight retention, yet long-term implications remain unknown. We aimed to assess whether gestational weight change was associated with mortality more than 50 years later.</p><p><strong>Methods: </strong>The Collaborative Perinatal Project (CPP) was a prospective US pregnancy cohort (1959-65). The CPP Mortality Linkage Study linked CPP participants to the National Death Index and Social Security Death Master File for vital status to 2016. Adjusted hazard ratios (HRs) with 95% CIs estimated associations between gestational weight gain and loss according to the 2009 National Academy of Medicine recommendations and mortality by pre-pregnancy BMI. The primary endpoint was all-cause mortality. Secondary endpoints included cardiovascular and diabetes underlying causes of mortality.</p><p><strong>Findings: </strong>Among 46 042 participants, 20 839 (45·3%) self-identified as Black and 21 287 (46·2%) as White. Median follow-up time was 52 years (IQR 45-54) and 17 901 (38·9%) participants died. For those who were underweight before pregnancy (BMI <18·5 kg/m<sup>2</sup>; 3809 [9·4%] of 40 689 before imputation for missing data]), weight change above recommendations was associated with increased cardiovascular mortality (HR 1·84 [95% CI 1·08-3·12]) but not all-cause mortality (1·14 [0·86-1·51]) or diabetes-related mortality (0·90 [0·13-6·35]). For those with a normal pre-pregnancy weight (BMI 18·5-24·9 kg/m<sup>2</sup>; 27 921 [68·6%]), weight change above recommendations was associated with increased all-cause (HR 1·09 [1·01-1·18]) and cardiovascular (1·20 [1·04-1·37]) mortality, but not diabetes-related mortality (0·95 [0·61-1·47]). For those who were overweight pre-pregnancy (BMI 25·0-29·9 kg/m<sup>2</sup>; 6251 [15·4%]), weight change above recommendations was associated with elevated all-cause (1·12 [1·01-1·24]) and diabetes-related (1·77 [1·23-2·54]) mortality, but not cardiovascular (1·12 [0·94-1·33]) mortality. For those with pre-pregnancy obesity (≥30·0 kg/m<sup>2</sup>; 2708 [6·7%]), all associations between gestational weight change and mortality had wide CIs and no meaningful relationships could be drawn. Weight change below recommended levels was associated only with a reduced diabetes-related mortality (0·62 [0·48-0·79]) in people with normal pre-pregnancy weight.</p><p><strong>Interpretation: </strong>This study's novel findings support the importance of achieving healthy gestational weight gain within recommendations, adding that the implications might extend beyond the pregnancy window to long-term health, including cardiovascular and diabetes-related mortality.</p><p><strong>Funding: </strong>National Institutes of Health.</p>","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"1857-1865"},"PeriodicalIF":98.4000,"publicationDate":"2023-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721111/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/S0140-6736(23)01517-9","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/19 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: High weight gain in pregnancy is associated with greater postpartum weight retention, yet long-term implications remain unknown. We aimed to assess whether gestational weight change was associated with mortality more than 50 years later.

Methods: The Collaborative Perinatal Project (CPP) was a prospective US pregnancy cohort (1959-65). The CPP Mortality Linkage Study linked CPP participants to the National Death Index and Social Security Death Master File for vital status to 2016. Adjusted hazard ratios (HRs) with 95% CIs estimated associations between gestational weight gain and loss according to the 2009 National Academy of Medicine recommendations and mortality by pre-pregnancy BMI. The primary endpoint was all-cause mortality. Secondary endpoints included cardiovascular and diabetes underlying causes of mortality.

Findings: Among 46 042 participants, 20 839 (45·3%) self-identified as Black and 21 287 (46·2%) as White. Median follow-up time was 52 years (IQR 45-54) and 17 901 (38·9%) participants died. For those who were underweight before pregnancy (BMI <18·5 kg/m2; 3809 [9·4%] of 40 689 before imputation for missing data]), weight change above recommendations was associated with increased cardiovascular mortality (HR 1·84 [95% CI 1·08-3·12]) but not all-cause mortality (1·14 [0·86-1·51]) or diabetes-related mortality (0·90 [0·13-6·35]). For those with a normal pre-pregnancy weight (BMI 18·5-24·9 kg/m2; 27 921 [68·6%]), weight change above recommendations was associated with increased all-cause (HR 1·09 [1·01-1·18]) and cardiovascular (1·20 [1·04-1·37]) mortality, but not diabetes-related mortality (0·95 [0·61-1·47]). For those who were overweight pre-pregnancy (BMI 25·0-29·9 kg/m2; 6251 [15·4%]), weight change above recommendations was associated with elevated all-cause (1·12 [1·01-1·24]) and diabetes-related (1·77 [1·23-2·54]) mortality, but not cardiovascular (1·12 [0·94-1·33]) mortality. For those with pre-pregnancy obesity (≥30·0 kg/m2; 2708 [6·7%]), all associations between gestational weight change and mortality had wide CIs and no meaningful relationships could be drawn. Weight change below recommended levels was associated only with a reduced diabetes-related mortality (0·62 [0·48-0·79]) in people with normal pre-pregnancy weight.

Interpretation: This study's novel findings support the importance of achieving healthy gestational weight gain within recommendations, adding that the implications might extend beyond the pregnancy window to long-term health, including cardiovascular and diabetes-related mortality.

Funding: National Institutes of Health.

不同妊娠队列的妊娠体重变化与50年死亡率:一项前瞻性观察性队列研究。
背景:妊娠期高体重增加与产后体重保持率较高有关,但其长期影响尚不清楚。我们旨在评估妊娠期体重变化是否与50多年后的死亡率相关。方法:围产期协作计划(CPP)是一个前瞻性的美国妊娠队列(1959-65)。CPP死亡率关联研究将CPP参与者与截至2016年的国家死亡指数和社会保障死亡主文件联系起来。根据2009年美国国家医学院的建议,95%置信区间的调整后危险比(HR)估计了妊娠期体重增加和减少与妊娠前BMI死亡率之间的相关性。主要终点是全因死亡率。次要终点包括心血管和糖尿病的潜在死亡原因。调查结果:46 042名参与者,20人 839人(45.3%)自称为黑人,21人 287(46.2%)为白色。中位随访时间为52年(IQR 45-54)和17年 901人(38.9%)死亡。对于那些在怀孕前体重不足的人(BMI 2;3809[9.4%]/40 689),高于建议的体重变化与心血管死亡率增加有关(HR 1.84[95%CI 1.08-3.12]),但与全因死亡率(1.14[0.86-1-51])或糖尿病相关死亡率(0.90[0.13-6.35])无关。对于那些孕前体重正常的人(BMI 18.5-24.9 kg/m2;27 921[68.6%]),高于建议的体重变化与全因死亡率(HR1.09[1.01-1.18])和心血管死亡率(1.20[1.04-1.37])增加相关,但与糖尿病相关死亡率(0.95[0.61-1.47])无关。对于那些孕前超重的人(BMI为25.0-29.9 kg/m2;6251[15.4%]),上述建议的体重变化与全因死亡率(1.12[1.01-1.24])和糖尿病相关死亡率(1.77[1.23-2.54])升高有关,但与心血管死亡率(1.12[0.94-1.33])无关。对于妊娠前肥胖(≥30.0 kg/m2;2708[6.7%])的患者,妊娠体重变化与死亡率之间的所有相关性均具有广泛的CI,并且无法得出有意义的关系。在孕前体重正常的人群中,低于推荐水平的体重变化仅与糖尿病相关死亡率降低相关(0.62[0.48-0.79])。解释:这项研究的新发现支持了在建议范围内实现健康妊娠体重增加的重要性,并补充说,这一影响可能会超出妊娠窗口,延伸到长期健康,包括心血管和糖尿病相关死亡率。资助:美国国立卫生研究院。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
The Lancet
The Lancet 医学-医学:内科
CiteScore
148.10
自引率
0.70%
发文量
2220
审稿时长
3 months
期刊介绍: The Lancet is a world-leading source of clinical, public health, and global health knowledge. It was founded in 1823 by Thomas Wakley and has been an independent, international weekly general medical journal since then. The journal has an Impact Factor of 168.9, ranking first among 167 general and internal medicine journals globally. It also has a Scopus CiteScore of 133·2, ranking it second among 830 general medicine journals. The Lancet's mission is to make science widely available to serve and transform society, positively impacting people's lives. Throughout its history, The Lancet has been dedicated to addressing urgent topics, initiating debate, providing context for scientific research, and influencing decision makers worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信